Thromboxane b2

Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.

Cross Reference

Introduction

To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Thromboxane b2?

Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Thromboxane b2

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Airway Obstruction D000402 13 associated lipids
Uremia D014511 33 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Hypoxia D000860 23 associated lipids
Graft Occlusion, Vascular D006083 11 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Adenocarcinoma D000230 166 associated lipids
Ovarian Neoplasms D010051 10 associated lipids
Pain D010146 64 associated lipids
Contusions D003288 3 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lung Diseases D008171 37 associated lipids
Lung Neoplasms D008175 171 associated lipids
Wounds and Injuries D014947 20 associated lipids
Pleurisy D010998 20 associated lipids
Burns D002056 34 associated lipids
Per page 10 20 50 100 | Total 293

PubChem Associated disorders and diseases

What pathways are associated with Thromboxane b2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Thromboxane b2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Thromboxane b2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

What genes are associated with Thromboxane b2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Thromboxane b2

Download all related citations
Per page 10 20 50 100 | Total 6367
Authors Title Published Journal PubMed Link
Davis KA et al. Prostanoids: early mediators in the secondary injury that develops after unilateral pulmonary contusion. 1999 J Trauma pmid:10338399
Ishihara S et al. Effects of long-term hemofiltration on circulating mediators and superoxide production during continuous endotoxin administration. 1999 J Trauma pmid:10338409
Tegeder I et al. Comparison of inhibitory effects of meloxicam and diclofenac on human thromboxane biosynthesis after single doses and at steady state. 1999 Clin. Pharmacol. Ther. pmid:10340919
Stanczyk FZ et al. Effect of oral contraceptives containing 20 and 35 micrograms ethinyl estradiol on urinary prostacyclin and thromboxane metabolite levels in smokers and nonsmokers. 1999 Contraception pmid:10342082
Spokas EG et al. Whole-blood assays for evaluation of thromboxane synthase inhibition. 1999 Methods Mol. Biol. pmid:10343321
Mita H et al. Generation of thromboxane A2 from highly purified human sinus mast cells after immunological stimulation. 1999 Prostaglandins Leukot. Essent. Fatty Acids pmid:10359019
Heidemann SM et al. Ibuprofen attenuates cardiopulmonary dysfunction by modifying vascular tone in endotoxemia. 1999 Prostaglandins Leukot. Essent. Fatty Acids pmid:10359020
Dickneite G and Leithäuser B Influence of antithrombin III on coagulation and inflammation in porcine septic shock. 1999 Arterioscler. Thromb. Vasc. Biol. pmid:10364091
Lees P et al. A pharmacodynamic and pharmacokinetic study with vedaprofen in an equine model of acute nonimmune inflammation. 1999 J. Vet. Pharmacol. Ther. pmid:10372594
Giuliano F and Warner TD Ex vivo assay to determine the cyclooxygenase selectivity of non-steroidal anti-inflammatory drugs. 1999 Br. J. Pharmacol. pmid:10372826
Xing X and Xia S Injury of liver sinusoidal endothelial cells in isolated liver perfusion model for regional chemotherapy in rats. 1998 Chin. Med. J. pmid:10374437
Mao E et al. [Pancreatic ischemia: a continuous injury factor in acute necrotic pancreatitis]. 1997 Zhonghua Wai Ke Za Zhi pmid:10374521
Ren YJ et al. Inhibitory effects of nimodipine on platelet aggregation and thrombosis. 1998 Zhongguo Yao Li Xue Bao pmid:10374642
Shan CW et al. Inhibitory effects of procainamide on rabbit platelet aggregation and thromboxane B2 production in vitro. 1998 Zhongguo Yao Li Xue Bao pmid:10374644
Tong H et al. Prostaglandin endoperoxide synthase-2 abundance is increased in brain tissues of late-gestation fetal sheep in response to cerebral hypoperfusion. 1999 May-Jun J. Soc. Gynecol. Investig. pmid:10376268
Praticó D et al. Iron-dependent human platelet activation and hydroxyl radical formation: involvement of protein kinase C. 1999 Circulation pmid:10377074
Carvalho C et al. A rat model presenting eosinophilia in the airways, lung eosinophil activation, and pulmonary hyperreactivity. 1999 Exp. Lung Res. pmid:10378102
Tanaka H et al. Leukotriene (LT)-receptor antagonist is more effective in asthmatic patients with a low baseline ratio of urinary LTE4 to 2,3-dinor-6-keto-prostaglandin (PG)F1alpha. 1999 Allergy pmid:10380781
Walsh SW et al. AA-2414, an antioxidant and thromboxane receptor blocker, completely inhibits peroxide-induced vasoconstriction in the human placenta. 1999 J. Pharmacol. Exp. Ther. pmid:10381779
Panara MR et al. Dose-dependent inhibition of platelet cyclooxygenase-1 and monocyte cyclooxygenase-2 by meloxicam in healthy subjects. 1999 J. Pharmacol. Exp. Ther. pmid:10381787
Freedman JE et al. Deficient platelet-derived nitric oxide and enhanced hemostasis in mice lacking the NOSIII gene. 1999 Circ. Res. pmid:10381894
Cryer B and Feldman M Effects of very low dose daily, long-term aspirin therapy on gastric, duodenal, and rectal prostaglandin levels and on mucosal injury in healthy humans. 1999 Gastroenterology pmid:10381905
Kubo K et al. A 21-aminosteroid, U-74006F, attenuates endotoxin-induced lung injury in awake sheep. 1999 Respirology pmid:10382236
Williams CA et al. The flavonoids of Tanacetum parthenium and T. vulgare and their anti-inflammatory properties. 1999 Phytochemistry pmid:10382317
Brown N et al. Comparison of antiplatelet activity of microencapsulated aspirin 162.5 Mg (Caspac XL), with enteric coated aspirin 75 mg and 150 mg in patients with atherosclerosis. 1999 Br J Clin Pharmacol pmid:10383561
Itasaka H et al. The mechanism of hepatic graft protection against reperfusion injury by prostaglandin E1. 1999 Surg. Today pmid:10385367
Maitra SR et al. Alterations in hepatic gluconeogenesis, prostanoid, and intracellular calcium during sepsis. 1999 Acad Emerg Med pmid:10386675
Bowers W et al. Artificial human skin: cytokine, prostaglandin, Hsp70 and histological responses to heat exposure. 1999 J. Dermatol. Sci. pmid:10397388
Peredo HA et al. Time-course of the alterations in prostanoid production and in contractile responses of mesenteric beds isolated from streptozotocin diabetic rats. 1999 Prostaglandins Leukot. Essent. Fatty Acids pmid:10397409
Saareks V et al. Nicotinic acid and pyridoxine modulate arachidonic acid metabolism in vitro and ex vivo in man. 1999 Pharmacol. Toxicol. pmid:10401729
Shen AY et al. Inhibition of 2-P-mercaptophenyl-1,4-naphthoquinone on human platelet function. 1999 Life Sci. pmid:10403492
Jönsson A et al. Effects of amide local anaesthetics on eicosanoid formation in burned skin. 1999 Acta Anaesthesiol Scand pmid:10408815
Morrow JD et al. Increased formation of thromboxane in vivo in humans with mastocytosis. 1999 J. Invest. Dermatol. pmid:10417625
Mercer JB et al. The effect of short-term cold exposure on risk factors for cardiovascular disease. 1999 Thromb. Res. pmid:10418798
Kawano K et al. Superiority of platelet integrin GPIIb-IIIa receptor antagonist over aspirin in preventing cyclic flow reductions in the guinea pig middle cerebral artery. 1999 Eur. J. Pharmacol. pmid:10422782
McCowan LM et al. Administration of low-dose aspirin to mothers with small for gestational age fetuses and abnormal umbilical Doppler studies to increase birthweight: a randomised double-blind controlled trial. 1999 Br J Obstet Gynaecol pmid:10428519
Hamberg M et al. A method for measurement of platelet regeneration in man. 1978 Prostaglandins Med pmid:104315
Mills JL et al. Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: a multicenter prospective study. 1999 JAMA pmid:10432033
Kim HS et al. Effects of tetrandrine and fangchinoline on human platelet aggregation and thromboxane B2 formation. 1999 J Ethnopharmacol pmid:10433485
van Kooten F et al. Increased thromboxane biosynthesis is associated with poststroke dementia. 1999 Stroke pmid:10436098
Ricetti MM et al. Effects of sodium selenite on in vitro interactions between platelets and endothelial cells. 1999 Int. J. Clin. Lab. Res. pmid:10436266
Tsugawa K et al. A selective cyclo-oxygenase-2 inhibitor, NS-398, may improve portal hypertension without inducing gastric mucosal injury. 1999 J. Gastroenterol. Hepatol. pmid:10440208
Licker M et al. Chronic angiotensin converting inhibition does not influence renal hemodynamic and function during cardiac surgery. 1999 Can J Anaesth pmid:10442956
Ogura S et al. Protective effect of tyrphostin AG-556 on shock induced by endotoxin or gram positive bacteria. 1999 Shock pmid:10446890
Zhang S et al. Effects of acupuncture on the levels of endothelin, TXB2, and 6-keto-PGF1 alpha in apoplexy patients. 1999 J Tradit Chin Med pmid:10453582
Arakida Y et al. Effects of lipid mediator antagonists on predominant mediator-controlled asthmatic reactions in passively sensitized guinea pigs. 1999 J. Pharmacol. Exp. Ther. pmid:10454505
Melton SM et al. Mediator-dependent secondary injury after unilateral blunt thoracic trauma. 1999 Shock pmid:10454828
Sheu JR et al. The antiplatelet activity of PMC, a potent alpha-tocopherol analogue, is mediated through inhibition of cyclo-oxygenase. 1999 Br. J. Pharmacol. pmid:10455267
Jiménez R et al. Involvement of thromboxane A2 in the endothelium-dependent contractions induced by myricetin in rat isolated aorta. 1999 Br. J. Pharmacol. pmid:10455307
Hino Y et al. Changes in endothelium-derived vascular regulatory factors during dobutamine-stress-induced silent myocardial ischemia in patients with Kawasaki disease. 1999 Jpn. Circ. J. pmid:10462014